GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
100 hedge funds and large institutions have $64M invested in Sanofi Contingent Value Rights in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Holders
100
Holding in Top 10
1
Calls
$612K
Puts
–
Top Buyers
| 1 | +$241K | |
| 2 | +$161K | |
| 3 | +$45.5K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$10.8K |
| 5 |
Goldman Sachs
New York
|
+$2.59K |
Top Sellers
| 1 | -$76K | |
| 2 | -$56K | |
| 3 | -$50.9K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$31.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$29K |